+1-626-295-2442 (Worldwide) 400-606-8865 (China)
Sign in Register
English

Global Inhaled Nitric Oxide Market is Projected to Reach US$ 1,266 Mn by 2023

Author: QYResearch | Publish date: 2018-08-17 | Views: 11
New report published by QY Research which offers insights on the global Inhaled Nitric Oxide market. The Inhaled Nitric Oxide market has been experiencing steady growth graph since past years. During the 2017-2023 timeline, the global market for Inhaled Nitric Oxide is expected to reflect 1.6 times increase in the revenue growth. In 2018 the global Inhaled Nitric Oxide market was valued at US$ 848 Mn and by the end of the assessment year (2023), it is estimated to touch a value more than US$ 1,266 Mn growing at a value CAGR of 8.32% throughout the period of forecast.

image.png

The leading companies own the advantages on better performance, more abundant product’s types, better technical and impeccable after-sales service. Consequently, they take the majority of the market share of high-end market. Looking to the future years, the slow upward price trend in recent years will maintain. As competition intensifies, prices gap between different brands will go narrowing. Similarly, there will be fluctuation in gross margin.


The industry is expected to remain innovation-led, with frequent acquisitions and strategic alliances adopted as the key strategies by the players to increase their industry presence. Market stays in mature period with a clear concentration. Meanwhile, optimize product mix and further develop value-added capabilities to maximize margins.


Market Segment by Manufacturers, this report covers

·        Mallinckrodt

·        Praxair

·        Air Liquide


Market Segment by Type, covers

·        99.92% Purity

·        99.99% Purity

·        Other


Market Segment by Applications, can be divided into

·        ARDS

·        PPHN

·        Other Diseases


Global Inhaled Nitric Oxide Market: Market Driver and Restraint

The Global Inhaled Nitric Oxide market size was 783.77 million USD in 2017 and it will be 1265.95 million USD in 2023, with a CAGR of 8.32% from 2017 to 2023. The Inhaled Nitric Oxide market is growing rapidly in accordance with the growth in the medical gas market. Inhaled NO therapy is commonly used in intensive care units to treat patients with adult respiratory distress syndrome (ARDS), and it appears that inhaled NO is effective in treating conditions that result in pulmonary hypertension, such as, persistent pulmonary hypertension of the neonate (PPHN), and in diseases characterized by disturbances in gas exchange, such as chronic obstructive pulmonary disease (COPD).


Global Inhaled Nitric Oxide Market: Key Takeaways

Though the gross margin is high, but with complex production process and acquisition between enterprises, we tend to believe that this market is going to keep the monopoly status in the forecast period.


Global Inhaled Nitric Oxide Market: Forecast by Region

According to the research, North America and Europe comprised the biggest consumption areas. Other markets like Japan and China are growing relatively slow.


Global Inhaled Nitric Oxide Market: Key Players

The market is highly concentrated, with high technical and professional level. Key vendors in this market are Mallinckrodt, Praxair and Air Liquide, they are taking up to 91.19% market share in 2017. Inhaled Nitric Oxide types commonly used in this market are 800 ppm and 100 ppm, small players tend to produce lower purity products, such as 1000 ppm or so.


Click to view the full report TOC, figure and tables

https://www.qyresearch.com/index/detail/235564/global-inhaled-nitric-oxide-sales-market


CONTACT US
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
Our clients
<
4321
>
>